成组序贯分析或可实现试验早期终止:一项观察者内重复性研究的示例
本文在45例卵巢癌患者术前FDG-PET/CT的观察者内重复性研究中,以SUVmax差值的总体标准差对假设值1.5进行序贯单侧检验,比较固定样本分析与事后定义的一、二、三次中期分析策略。以三分之一和三分之二患者进行中期分析时,可在首次中期分析及最终分析后判定一致性充分;其他划分因一个强影响离群值及样本量小,经多重检验校正后未提示可提前终止。作者认为成组序贯检验可能使试验提前终止,从而潜在节省时间与资源。
要点
- 45例卵巢癌患者术前FDG-PET/CT的SUVmax由同一观察者测定两次,对差值总体标准差与假设值1.5做序贯单侧检验。
- 以三分之一和三分之二患者行中期分析时,首次中期分析及最终分析后可判定一致性充分。
- 其他划分因一个强影响离群值及样本量小,经多重检验校正后未提示可提前终止。
核心结论
- 作者认为成组序贯检验可能使试验提前终止,从而潜在节省时间与资源。
- 作者指出检验策略必须在计划阶段定义,且中期分析时样本量须足够大,以确保对单个离群值的稳健性。
- 作者认为成组序贯检验在准确性与一致性研究中可能有一席之地。
研究设计与样本
- 观察者内重复性研究,纳入45例卵巢癌患者,从术前FDG-PET/CT测定原发灶SUVmax两次。
- 假定SUVmax差值呈正态分布,对差值总体标准差与假设值1.5进行序贯单侧假设检验,采用alpha消耗函数。
- 将固定样本分析(N=45)与事后定义的含1次(N=23)、2次(N=15、30)或3次(N=11、23、34)中期分析的成组序贯分析策略进行比较。
主要发现
- 以三分之一和三分之二患者进行中期分析时,首次中期分析及最终分析后可判定一致性充分。
- 其他划分因一个强影响离群值及样本量小,经多重检验校正后未提示可提前终止。
关键数值与推荐
- SUVmax差值的总体标准差对假设值1.5进行序贯单侧检验。
- 固定样本分析N=45;成组序贯策略中期分析分别为N=23、N=15与30、N=11、23与34,均事后定义。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文指出其他划分因一个强影响离群值及样本量小,经多重检验校正后未提示可提前终止。
- 原文指出检验策略必须在计划阶段定义,且中期分析时样本量须足够大,以确保对单个离群值的稳健性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Group-sequential testing is widely used in pivotal therapeutic, but rarely in diagnostic research, although it may save studies, time, and costs. The purpose of this paper was to demonstrate a group-sequential analysis strategy in an intra-observer study on quantitative FDG-PET/CT measurements, illuminating the possibility of early trial termination which implicates significant potential time and resource savings. METHODS: Primary lesion maximum standardised uptake value (SUVmax) was determined twice from preoperative FDG-PET/CTs in 45 ovarian cancer patients. Differences in SUVmax were assumed to be normally distributed, and sequential one-sided hypothesis tests on the population standard deviation of the differences against a hypothesised value of 1.5 were performed, employing an alpha spending function. The fixed-sample analysis (N = 45) was compared with the group-sequential analysis strategies comprising one (at N = 23), two (at N = 15, 30), or three interim analyses (at N = 11, 23, 34), respectively, which were defined post hoc. RESULTS: When performing interim analyses with one third and two thirds of patients, sufficient agreement could be concluded after the first interim analysis and the final analysis. Other partitions did not suggest early stopping after adjustment for multiple testing due to one influential outlier and our small sample size. CONCLUSIONS: Group-sequential testing may enable early stopping of a trial, allowing for potential time and resource savings. The testing strategy must, though, be defined at the planning stage, and sample sizes must be reasonably large at interim analysis to ensure robustness against single outliers. Group-sequential testing may have a place in accuracy and agreement studies.
引用
- Gerke O, Vilstrup MH, Halekoh U, et al. Group-sequential analysis may allow for early trial termination: illustration by an intra-observer repeatability study. EJNMMI Res. 2017. PMID: 28952076. doi:10.1186/s13550-017-0328-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。